Baljiwan Medicines Private Limited - Company Profile

It is a healthcare private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1989.
1989 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Baljiwan Medicines Private Limited

Baljiwan Medicines Private Limited, a active private limited company, was established on 14 September 1989 in Uttar Pradesh, Uttar Pradesh, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231UP1989PTC011170. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.30 M.

It upholds a compliant status. Employing 22 professional, Its leadership includes Saurabh Agarwal (Director), Richa Agrawal (Director). Past directors included Jyoti Swaroop Agarwal, Shanti Swaroop Agrawal, Vinayaka Agrawal. It holds ₹1.23 Cr open charges and ₹5.25 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5Th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, Uttar Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231UP1989PTC011170

  • Registration Number

    011170

  • Incorporation Date

    14 September 1989

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.30 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.30 M
  • Company Age 36 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.23 Cr
  • Satisfied Charges ₹ 5.25 M
  • Revenue Growth **** 25.97%
  • Profit Growth **** 5.15%
  • Ebitda **** 50.46%
  • Net Worth 4.89%
  • Total Assets **** 8.86%
Company report

Baljiwan Medicines Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Baljiwan Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Baljiwan Medicines Private Limited?
Current Directors
Name Designation Appointment Date Status
Saurabh Agarwal Director 20 Apr 2015 Current
Richa Agrawal Director 20 Apr 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 08 May 2016 Past
Pramod Abcsdd Director 12 Feb 2010 Past
Pramod Abcsdd Director 07 Nov 2015 Past
Pramod Abcsdd Director 07 Nov 2015 Past
Pramod Abcsdd Director 08 Nov 2023 Past
Pramod Abcsdd Director 07 Nov 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Baljiwan Medicines.

Baljiwan Medicines Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.97% increase. The company also saw a slight improvement in profitability, with a 5.15% increase in profit. The company's net worth moved up by a moderate rise of 4.89%.

Baljiwan Medicines revenue growth over time
Baljiwan Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.97%
*******
*******
*******
*******
Revenue from Operations
*******
 30.72%
*******
*******
*******
*******
Total Assets
*******
 8.86%
*******
*******
*******
*******
Profit or Loss
*******
 5.15%
*******
*******
*******
*******
Net Worth
*******
 4.89%
*******
*******
*******
*******
EBITDA
*******
 50.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Baljiwan Medicines?

In 2021, Baljiwan Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,250,000.00

Satisfied Charges

₹5,250,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.23 Cr
Latest Charge Details
Date Lender Amount Status
10 Jun 2022 Canara Bank ₹1.00 M Open
21 Aug 2017 Canara Bank ₹1.25 M Open
21 Aug 2017 Canara Bank ₹1.00 Cr Open
15 Apr 2020 Canara Bank ₹3.50 M Satisfied
31 Mar 2018 Canara Bank ₹1.75 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Baljiwan Medicines?

Baljiwan Medicines has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Baljiwan Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baljiwan Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Baljiwan Medicines
Recent Activity within the Organization
  • Annual General Meeting

    The activity Baljiwan Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Baljiwan Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Charges

    Progress on A charge registered on 31 Mar 2018 via Charge ID 100176408 with Canara Bank was fully satisfied on 26 Oct 2023. was documented.

  • Charges

    The activity A charge registered on 15 Apr 2020 via Charge ID 100341096 with Canara Bank was fully satisfied on 10 Aug 2023. was completed.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100583720 was registered on 10 Jun 2022. was documented.

  • Charges

    A charge with Canara Bank amounted to Rs. 3.50 M with Charge ID 100341096 was registered on 15 Apr 2020. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Baljiwan Medicines Private Limited?

The CIN of Baljiwan Medicines Private Limited is U24231UP1989PTC011170.

Where is Baljiwan Medicines Private Limited headquartered?

Baljiwan Medicines Private Limited is headquartered at 5Th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, Uttar Pradesh.

When was Baljiwan Medicines Private Limited incorporated?

Baljiwan Medicines Private Limited was incorporated on 14 September 1989.

Who are the current directors of Baljiwan Medicines Private Limited?

The current directors of Baljiwan Medicines Private Limited are

What is the primary industry of Baljiwan Medicines Private Limited?

The primary industry of Baljiwan Medicines Private Limited is Manufacturing.

Is Baljiwan Medicines Private Limited a listed company?

Baljiwan Medicines Private Limited is unlisted.

What is the capital structure of Baljiwan Medicines Private Limited?

The authorized capital of Baljiwan Medicines Private Limited is ₹2.50 M, and the paid-up capital is ₹1.30 M.

What is the compliance status of Baljiwan Medicines Private Limited?

The compliance status of Baljiwan Medicines Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available